To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
NCT07374406
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Epaminurad 9 mg (JW Pharmaceutical)
DRUG:
Epaminurad 9 mg (Shanghai STA Pharmaceutical)
Sponsor
JW Pharmaceutical